Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.
Phase 3
Completed
- Conditions
- Hygiene
- Interventions
- Drug: Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower
- Registration Number
- NCT00785850
- Lead Sponsor
- Sanofi
- Brief Summary
To prove the safety in normal conditions of use.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 31
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description 1 Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower
- Primary Outcome Measures
Name Time Method The absence of irritation and the good acceptability will be evaluated using one specific scale which describes the intensity of the reaction. From the treatment start to the end of the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sanofi-Aventis Administrative Office
🇧🇷Sao Paulo, Brazil